Using AI To Personalize Healthcare–Without Losing Patient Trust
In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize…
Life Biosciences lands $80m to push cell reset therapy
Fresh funding backs the first human trial of a therapy designed to make older, damaged cells act younger…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
Why clinical trials on nutritional supplements are hard to design
Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
Klothea initiates longevity-focused human trial of klotho therapy
Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
Fact Check Team: GLP-1 users getting rare pirate disease
WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints News
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways Successfully Achieves Primary…
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
Spanish scientist finds cure for pancreatic cancer in major medical breakthrough |
A Spanish research team says it has developed a treatment that completely eliminated the most aggressive form of…
FDA rejects Vanda’s jet lag drug following yearslong dispute and 'long-shot' review – Endpoints News
FDA rejects Vanda’s jet lag drug following yearslong dispute and ‘long-shot’ review Endpoints NewsFDA rejects Vanda’s jet lag treatment…